Actelion (now Janssen Pulmonary Hypertension)
now Janssen Pulmonary Hypertension
- B2B
- Has physical offices
- Manufacturing
- Sales-led purchase
About Actelion (now Janssen Pulmonary Hypertension)
Now operating under Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on pulmonary hypertension with a dedicated LinkedIn channel for updates.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Basel, Vaud, Switzerland
- Revenue
- $97.6M – $771MTamtam estimate
- Website
- jnj.com
Actelion (now Janssen Pulmonary Hypertension) at a glance
Actelion (now Janssen Pulmonary Hypertension) is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Basel, Vaud, Switzerland.
Actelion (now Janssen Pulmonary Hypertension) has 251–1,000 employees.
Actelion (now Janssen Pulmonary Hypertension)'s revenue is $97.6M – $771M (Tamtam estimate).
Frequently asked questions about Actelion (now Janssen Pulmonary Hypertension)
What is Actelion (now Janssen Pulmonary Hypertension)'s revenue?
Tamtam estimates Actelion (now Janssen Pulmonary Hypertension)'s annual revenue at $97.6M – $771M.
How many employees does Actelion (now Janssen Pulmonary Hypertension) have?
Actelion (now Janssen Pulmonary Hypertension) has 251–1,000 employees.
Where is Actelion (now Janssen Pulmonary Hypertension) headquartered?
Actelion (now Janssen Pulmonary Hypertension) is headquartered in Basel, Vaud, Switzerland.
Selling to companies like Actelion (now Janssen Pulmonary Hypertension)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies